Research ArticleArticle
The Antiallergic Mast Cell Stabilizers Lodoxamide and Bufrolin as the First High and Equipotent Agonists of Human and Rat GPR35
Amanda E MacKenzie, Gianluigi Caltabiano, Toby C Kent, Laura Jenkins, Jennifer E McCallum, Brian D Hudson, Stuart A Nicklin, Lindsay Fawcett, Rachel Lane, Steven J Charlton and Graeme Milligan
Molecular Pharmacology October 10, 2013, mol.113.089482; DOI: https://doi.org/10.1124/mol.113.089482
Amanda E MacKenzie
1 University of Glasgow;
Gianluigi Caltabiano
2 Universitat Autonoma de Barcelona;
Toby C Kent
3 Novartis
Laura Jenkins
1 University of Glasgow;
Jennifer E McCallum
1 University of Glasgow;
Brian D Hudson
1 University of Glasgow;
Stuart A Nicklin
1 University of Glasgow;
Lindsay Fawcett
3 Novartis
Rachel Lane
3 Novartis
Steven J Charlton
3 Novartis
Graeme Milligan
1 University of Glasgow;
Jump to comment:
No eLetters have been published for this article.
In this issue
Research ArticleArticle
The Antiallergic Mast Cell Stabilizers Lodoxamide and Bufrolin as the First High and Equipotent Agonists of Human and Rat GPR35
Amanda E MacKenzie, Gianluigi Caltabiano, Toby C Kent, Laura Jenkins, Jennifer E McCallum, Brian D Hudson, Stuart A Nicklin, Lindsay Fawcett, Rachel Lane, Steven J Charlton and Graeme Milligan
Molecular Pharmacology October 10, 2013, mol.113.089482; DOI: https://doi.org/10.1124/mol.113.089482
Research ArticleArticle
The Antiallergic Mast Cell Stabilizers Lodoxamide and Bufrolin as the First High and Equipotent Agonists of Human and Rat GPR35
Amanda E MacKenzie, Gianluigi Caltabiano, Toby C Kent, Laura Jenkins, Jennifer E McCallum, Brian D Hudson, Stuart A Nicklin, Lindsay Fawcett, Rachel Lane, Steven J Charlton and Graeme Milligan
Molecular Pharmacology October 10, 2013, mol.113.089482; DOI: https://doi.org/10.1124/mol.113.089482
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement